AACR Annual Meeting 2018

Highlights from the AACR Annual Meeting 2018

Driving Innovative Cancer Science to Patient Care

April 14-18, 2018
Chicago, Illinois

Program Committee Chair
Elaine R. Mardis, Nationwide Children's Hospital, Columbus, Ohio

The 109th Annual Meeting of the American Association for Cancer Research was the largest meeting ever, as more than 22,500 laboratory researchers, clinicians, patient advocates, and other oncology professionals from around the world gathered to share the latest innovative cancer science. As the leading forum for cutting edge basic, translational, and clinical discoveries, the AACR Annual Meeting sets the research agenda for the cancer community.

Meeting Highlights

Meeting Summaries. Cancer Research Catalyst (the AACR blog) and Cancer Today (the AACR's magazine for patients, survivors, and caregivers) covered the meeting in depth, highlighting both the cutting-edge science presented at the meeting as well as the perspective of patient advocates who participated in the AACR Scientist-Survivor Program. In addition, meeting attendees received expert summaries of the scientific highlights during a Wrap-Up Plenary Session.
Cancer Research Catalyst  |  Cancer Today  |  Webcast: Wrap-Up Plenary

Meeting Webcasts. The audio and slides of nearly 200 presentationsincluding all Plenary Session presentationsare available free to everyone. The complete meeting webcast, consisting of more the 850 presentations, is available free to paid registrants or for purchase to non-attendees.
Webcasts  |  Login/Purchase Information

Abstracts and Posters. Nearly 6,300 abstracts were presented at the meeting in poster sessions or minisymposia. These abstracts are freely available in multiple formats.
Online  |  eBook  |  PDF (17 MB)  |  ePosters

Media Coverage/Social Media Impact. The meeting generated global interest as illustrated by the significant amount of news coverage and social media activity.

Spotlight on Clinical Trials. Nearly 170 clinical trials were presented at the Annual Meeting. The highest-impact trials were featured in Clinical Trials Plenary Sessions, including a phase III trial on "Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma."
Webcasts and Abstracts

NCI Director's Address. Norman E. Sharpless, MD, shared some of his key focus areas for the NCI with Annual Meeting attendees. The meeting program also included several NCI/NIH-sponsored sessions.
Webcast  |  Q&A in Cancer Discovery

Regulatory Science and Science Policy Sessions. These sessions highlighted recent regulatory developments and provided an open forum for the discussion of cutting-edge issues in cancer drug, biologic, and diagnostic regulation.
Webcasts  |  Session Summaries

Professional Development Opportunities. The AACR provided Annual Meeting attendees at all career stages—from high school students to senior investigators—with the resources to enhance and advance their careers.
Professional Development Opportunities  |  NextGen Stars

Top of page